Literature DB >> 11600681

A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating.

J Fu1, H L Ji, A P Naren, K L Kirk.   

Abstract

1. The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is activated by protein kinase A (PKA) phosphorylation of its R domain and by ATP binding at its nucleotide-binding domains (NBDs). Here we investigated the functional role of a cluster of acidic residues in the amino terminal tail (N-tail) that also modulate CFTR channel gating by an unknown mechanism. 2. A disease-associated mutant that lacks one of these acidic residues (D58N CFTR) exhibited lower macroscopic currents in Xenopus oocytes and faster deactivation following washout of a cAMP -activating cocktail than wild-type CFTR. 3. In excised membrane patches D58N CFTR exhibited a two-fold reduction in single channel open probability due primarily to shortened open channel bursts. 4. Replacing this and two nearby acidic residues with alanines (D47A, E54A, D58A) also reduced channel activity, but had negligible effects on bulk PKA phosphorylation or on the ATP dependence of channel activation. 5. Conversely, the N-tail triple mutant exhibited a markedly inhibited response to AMP-PNP, a poorly hydrolysable ATP analogue that can nearly lock open the wild-type channel. The N-tail mutant had both a slower response to AMP-PNP (activation half-time of 140 +/- 20 s vs. 21 +/- 4 s for wild type) and a lower steady-state open probability following AMP-PNP addition (0.68 +/- 0.08 vs. 0.92 +/- 0.03 for wild type). 6. Introducing the N-tail mutations into K1250A CFTR, an NBD2 hydrolysis mutant that normally exhibits very long open channel bursts, destabilized the activity of this mutant as evidenced by decreased macroscopic currents and shortened open channel bursts. 7. We propose that this cluster of acidic residues modulates the stability of CFTR channel openings at a step that is downstream of ATP binding and upstream of ATP hydrolysis, probably at NBD2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600681      PMCID: PMC2278861          DOI: 10.1111/j.1469-7793.2001.0459c.xd

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

1.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

2.  Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.

Authors:  S C Hyde; P Emsley; M J Hartshorn; M M Mimmack; U Gileadi; S R Pearce; M P Gallagher; D R Gill; R E Hubbard; C F Higgins
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

3.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl(-) currents.

Authors:  A P Naren; A Di; E Cormet-Boyaka; P N Boyaka; J R McGhee; W Zhou; K Akagawa; T Fujiwara; U Thome; J F Engelhardt; D J Nelson; K L Kirk
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  Regulation of CFTR Cl- channel gating by ATP binding and hydrolysis.

Authors:  M Ikuma; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  CFTR chloride channel regulation by an interdomain interaction.

Authors:  A P Naren; E Cormet-Boyaka; J Fu; M Villain; J E Blalock; M W Quick; K L Kirk
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

7.  Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains.

Authors:  L Csanády; K W Chan; D Seto-Young; D C Kopsco; A C Nairn; D C Gadsby
Journal:  J Gen Physiol       Date:  2000-09       Impact factor: 4.086

8.  The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating.

Authors:  A A Aleksandrov; X Chang; L Aleksandrov; J R Riordan
Journal:  J Physiol       Date:  2000-10-15       Impact factor: 5.182

9.  Chloride impermeability in cystic fibrosis.

Authors:  P M Quinton
Journal:  Nature       Date:  1983-02-03       Impact factor: 49.962

10.  Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.

Authors:  K W Chan; L Csanády; D Seto-Young; A C Nairn; D C Gadsby
Journal:  J Gen Physiol       Date:  2000-08       Impact factor: 4.086

View more
  17 in total

1.  Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR.

Authors:  William R Thelin; Yun Chen; Martina Gentzsch; Silvia M Kreda; Jennifer L Sallee; Cameron O Scarlett; Christoph H Borchers; Ken Jacobson; M Jackson Stutts; Sharon L Milgram
Journal:  J Clin Invest       Date:  2007-01-18       Impact factor: 14.808

2.  Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia.

Authors:  Lynda S Ostedgaard; Christoph Randak; Tatiana Rokhlina; Philip Karp; Daniel Vermeer; Katherine J Ashbourne Excoffon; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

3.  Novel adenoviral vectors coding for GFP-tagged wtCFTR and deltaF508-CFTR: characterization of expression and electrophysiological properties in A549 cells.

Authors:  Horia Vais; Guang-Ping Gao; Michael Yang; Phoi Tran; Jean-Pierre Louboutin; Suryanarayan Somanathan; James M Wilson; William W Reenstra
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

4.  Protein kinase-independent activation of CFTR by phosphatidylinositol phosphates.

Authors:  Bettina Himmel; Georg Nagel
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

5.  Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR.

Authors:  Zhe Xu; Luísa S Pissarra; Carlos M Farinha; Jia Liu; Zhiwei Cai; Patrick H Thibodeau; Margarida D Amaral; David N Sheppard
Journal:  J Physiol       Date:  2014-03-03       Impact factor: 5.182

Review 6.  Structural mechanisms of CFTR function and dysfunction.

Authors:  Tzyh-Chang Hwang; Jiunn-Tyng Yeh; Jingyao Zhang; Ying-Chun Yu; Han-I Yeh; Samantha Destefano
Journal:  J Gen Physiol       Date:  2018-03-26       Impact factor: 4.086

7.  Gabapentin activates ROMK1 channels by a protein kinase A (PKA)-dependent mechanism.

Authors:  C-H Lee; T-S Tsai; H-H Liou
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

8.  An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening.

Authors:  Wei Wang; Bryan C Roessler; Kevin L Kirk
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

Review 9.  Imaging CFTR in its native environment.

Authors:  Hermann Schillers
Journal:  Pflugers Arch       Date:  2007-12-05       Impact factor: 3.657

10.  Improved fluorescence assays to measure the defects associated with F508del-CFTR allow identification of new active compounds.

Authors:  Emily Langron; Michela I Simone; Clémence M S Delalande; Jean-Louis Reymond; David L Selwood; Paola Vergani
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.